The short answer
Review green tea leaf extract with your pharmacist before use with methamphetamine, especially if it contains caffeine. Increased blood pressure is reported with some extracts, but the exact combination has not been shown to cause QT prolongation or arrhythmia.
What this answer covers
Camellia sinensis leaf extract; caffeine-containing, decaffeinated and brewed-tea preparations are not interchangeable.
- Supplement or preparation
- Camellia Sinensis Leaf Extract
- Medication ingredient
- methamphetamine
The ingredient list matters
Green tea extracts differ in caffeine and other constituents. Check the actual serving, whether the extract is decaffeinated, and whether a blend adds other stimulants. Brewed tea is a different exposure.
Blood-pressure findings are not uniform
NCCIH lists increased blood pressure among possible extract adverse effects. In contrast, a three-month trial of one extract in adults with obesity and hypertension found lower pressure than placebo. Neither result defines every product or this combination.
What remains unknown about heart rhythm
The inspected sources do not demonstrate QT prolongation or an arrhythmia interaction between this extract and methamphetamine. Methamphetamine still requires blood-pressure and pulse monitoring. A dose gap has not been shown to remove a risk.
Symptoms that need attention
Seek urgent medical care for chest pain, shortness of breath or fainting while taking methamphetamine. Tell your prescriber about new palpitations, troublesome stimulation or sleep disruption, and let the treating team decide on medication changes.
Evidence and practical considerations
Side effects & toxicity
Product-dependent blood-pressure and stimulant concerns justify review, while the broader exact-pair QT and arrhythmia claim is unproven.
- Exact scope
- Camellia sinensis leaf extract; caffeine-containing, decaffeinated and brewed-tea preparations are not interchangeable. with Prescribed oral S-methamphetamine hydrochloride; RxNorm 6816 IN and label section 11 establish active-moiety relationship, not dose or stereoisomer interchangeability.
- Medication form and route
- oral
- Timing or duration
- Dose, pattern of use and preparation matter; no universal protective spacing interval established.
What remains uncertain
- No exact co-use study; extract trial results include lower blood pressure and cannot establish safety with methamphetamine.
Factors that may matter: exact product; other medicines; prescribed dose; baseline cardiovascular or serotonergic risk.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral methamphetamine hydrochloride tablets.
Sections 2.4 and 7.1 identify acidifying agents such as ascorbic acid as lowering levels and alkalinizing agents such as sodium bicarbonate as increasing levels; avoid gastrointestinal and urinary alkalinizing co-use. Sections 5.8 and 7.1 warn about serotonin syndrome with serotonergic agents, specifically including tryptophan and St Johns wort. Section 5.3 calls for blood-pressure and pulse monitoring.
How this applies: RxNorm 6816 IN maps to this SPL, and description confirms active ingredient salt relationship. Applies to prescribed oral S-methamphetamine hydrochloride, not other stimulants or unapproved routes.
Regulatory guidance is not a quantified trial for every named pair. No one-hour supplement spacing instruction. General amphetamine language is explicitly incorporated in this exact methamphetamine product label.
Source 2: official guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Green tea product users.
Some extract adverse effects include increased blood pressure; product composition and caffeine vary.
How this applies: Supports product-specific review, not a proven QT interaction.
No exact methamphetamine trial; effects of extracts are not automatically effects of brewed tea or isolated catechins.
Source 3: original clinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 56 adults with obesity and hypertension.
Systolic and diastolic blood pressures decreased relative to placebo.
How this applies: Supports only the specific result and preparation described; applicability to prescribed oral methamphetamine is explicitly limited.
No methamphetamine co-use trial. Abstract does not establish every product caffeine content. Longer-term selected-population result is not an acute co-use safety clearance.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current available claims adjudicated from inspected sources; no clinical review asserted. | |
| Research summary published |
Article revision: 54f787a23454de14
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.